CFL1 restores the migratory capacity of bone marrow mesenchymal stem cells in primary Sjögren's syndrome by regulating CCR1 expression

Mengxi Huang(Nanjing University of Chinese Medicine), Lingyun Sun(Anhui Medical University), Genhong Yao(Nanjing Drum Tower Hospital), Xiaojun Tang(Nanjing Drum Tower Hospital), Dan Wu(Nanjing Drum Tower Hospital), Hang Yang(Hubei University), Zhou Panpan(Nanjing University of Chinese Medicine), Nan Zhao(Army Medical University)
International Immunopharmacology
January 5, 2024
10.1016/j.intimp.2024.111485
Cited by 5

Related Papers

Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus
|Arthritis & Rheumatism|2010|481
Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial
|The Lancet Oncology|2021|436
Allogeneic Mesenchymal Stem Cell Transplantation in Severe and Refractory Systemic Lupus Erythematosus: 4 Years of Experience
|Cell Transplantation|2013|273
Allogeneic CD19-targeted CAR-T therapy in patients with severe myositis and systemic sclerosis
|Cell|2024|272
H3N2 Mismatch of 2014–15 Northern Hemisphere Influenza Vaccines and Head-to-head Comparison between Human and Ferret Antisera derived Antigenic Maps
|Scientific Reports|2015|161